您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (2): 45-49.doi: 10.6040/j.issn.1671-7554.0.2016.1238

• 放射性粒子植入治疗肿瘤专题 • 上一篇    下一篇

3D打印个体化模板联合CT引导125I粒子植入治疗肿瘤术前术后剂量学比较

张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇   

  1. 山东大学附属省立医院东院保健综合(肿瘤)科, 山东 济南 250014
  • 收稿日期:2016-09-13 出版日期:2017-02-10 发布日期:2017-02-10
  • 通讯作者: 韩明勇. E-mail:hangmingyong@sina.com E-mail:hangmingyong@sina.com
  • 基金资助:
    国家自然科学基金(81272351)

A dosimetric study of 3D print individual template combination with CT-guided 125I seed implantation for malignant tumors

ZHANG Ying, LIN Qi, YUAN Yuan, DAI Jianjian, GENG Baocheng, XU Ruicai, LIU Yakun, HAN Mingyong   

  1. Department of Health Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2016-09-13 Online:2017-02-10 Published:2017-02-10

PDF (PC)

197

摘要： 目的 比较3D打印个体化模板联合CT引导125I粒子植入术后验证与术前计划剂量学参数的差异,探讨其在剂量学中的作用。 方法 收集2016年2月至10月住院患者37例,对每例患者设计3D打印个体化模板。在3D打印个体化模板引导下进行粒子植入手术,术后即刻行CT扫描并进行剂量学验证。比较手术前后植入参数和剂量学参数。 结果 37例患者模板均成功设计打印。术前临床靶体积(CTV)的范围是5.9~133.1 cc,平均为(36.1±31.3)cc;术后验证CTV范围是5.9~133.6 cc,平均(37.1±36.6)cc,两者比较差异有统计学意义(P<0.001)。处方剂量为100~160 Gy。术前计划粒子数为18~80颗,术后实际植入粒子数为24~84颗,其中2、6、12、14、15、21号患者分别补植了1~9颗不等的粒子。术前计划D90范围107.1~187.8 Gy,平均(144.7±18.8)Gy,术后验证D90范围是103.9~189.3 Gy,平均(143.3±20.3)Gy,两者比较差异无统计学意义(P=0.06)。术前计划V100的范围是83.7%~99.9%,平均(96.4±3.1)%,术后验证V100范围是85.2%~100%,平均(96.9±3.3)%,两者比较差异有统计学意义(P=0.002)。 结论 3D打印个体化模板联合CT引导粒子植入治疗恶性肿瘤能够保证术后剂量学指标的质量控制,但术前计划剂量学分布与术后验证仍存在一定差异,多方面原因及经验需继续分析总结。

关键词: 剂量学, 125I粒子, 3D打印, 个体化模板

Abstract: Objective To explore the use of 3D print individual template and CT-guided 125I seed implantation in dosimetry by comparing the parameters before and after implantation. Methods A total of 37 patients treated during Feb. and Oct. 2016 were involved. Before implantation, all patients underwent CT scan and the data were saved in digital imaging and communications in medicine(DICOM)format. The individual template was designed by brachytherapy treatment planning system(BTPS), and printed by 3D print technique. Patients received 125I seeds interstitial implantation with the guide of individual template and CT. After implantation, CT scan was performed immediately for dosimetric verification. The pre- and post-operative parameters were compared. Results All 37 individual templates were successfully designed and printed. The range of clinical target volume(CTV)was 5.9-133.1 cc［averaged(36.1±31.3)cc］ vs 5.9-133.6 cc［averaged(37.1±36.6)cc］ in preplan and post implantation, and there was significant difference 山 东 大 学 学 报 (医 学 版)55卷2期 -张颖,等.3D打印个体化模板联合CT引导125I粒子植入治疗肿瘤术前术后剂量学比较 \=-(P<0.001). The prescription dose(PD)was 100-160 Gy. The numbers of preplan seeds and actually implanted seeds were 18-80 vs 24-84. Patients No.2, 6, 12, 14, 15, and 21 received 1-9 complemented seeds during the surgery. The range of D90 was 107.1-187.8 Gy［averaged(144.7±18.8)Gy］ vs 103.9-189.3 Gy［averaged(143.3±20.3)Gy］ in preplan and post implantation, and there was no significant difference(P=0.06). The range of V100 was 83.7%-99.9% ［averaged(96.4±3.1)%］ vs 85.2%-100% ［averaged( 96.9±3.3)%］ in preplan and post implantation, and there was significant difference(P=0.002). Conclusion 3D print individual template and CT-guided 125I seed implantation can ensure the dosimetric quality control in the treatment of malignant tumors, but there are some differences between the preplan and postoperative parameters. Therefore, more clinical experiences still need to be summarized and analyzed.

Key words: Individual template, Iodine-125 seed, Dosimetry, 3D printing

中图分类号: 

  • R730.55
[1] Stewart A, Parashar B, Patel M, et al. American brachytherapy society consensus guidelines for thoracic brachytherapy for lung cancer[J]. Brachytherapy, 2016, 15(1): 1-11.
[2] Kovtun KA, Wolfsberger L, Niedermayr T, et al. Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: Implications for the use of newer isotopes[J]. Brachytherapy, 2014, 13(2): 152-156.
[3] Huo X, Wang H, Yang J, et al. Effectiveness and safety of CT-guided 125I seed brachytherapy for postoperative locoregional recurrence in patients with none-small cell lung cancer[J]. Brachytherapy, 2016, 15(3): 370-380.
[4] Feng S, Wang L, Xiao Z, et al. 125I seed implant brachytherapy for painful bone metastases after failure of external beam radiation therapy[J]. Medicine, 2015, 94(31): e1253. doi: 10.1097/MD.0000000000001253.
[5] Michalski MH, Ross JS. The shape of things to come: 3D printing in medicine[J]. JAMA, 2014, 312(21): 2213-2214.
[6] Nag S, Bice W, De Wyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplantdosimetric analysis[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1): 221-230.
[7] Lee EK, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants[J]. Int J Radiat Oncol Biol Phys, 2003, 56(3): 854-861.
[8] Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No 43[J]. Med Phys, 1995, 22(2): 209-234.
[9] Kovtun KA, Wolfsberger L, Niedermayr T, et al. Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: Implications for the use of newer isotopes[J]. Brachytherapy, 2014, 13(2): 152-156.
[10] Marcu LG, Lawson JM. Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants[J]. Br J Radiol, 2013, 86(1026): 20130058. doi: 10.1259/bjr.20130058. Epub 2013 Mar 21.
[11] Huang MW, Liu SM, Zhang JG. A digital model individual template and CT-guided 125I seed implants for malignant tumors of the head and neck[J]. J Radiat Res, 2012, 53(6): 973-977.
[12] Ikushima H. Radiation therapy: state of the art and the future[J]. J Med Invest, 2010, 57(1-2):1-11.
[13] Kupelian PA, Ramsey C, Meeks SL, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment[J]. Int J Radiat Oncol Biol Phys, 2005, 63(4): 1024-1028.
[14] 王俊杰, 林蕾. 放射性125I粒子置入治疗非小细胞肺癌进展[J]. 癌症进展, 2013, 1(2): 122-125.
[15] Nag S, Kelly JF, Horton JL, et al. Brachytherapy for carcinoma of lung[J]. Oncology(Williston Park), 2001, 15(3): 371-381.
[16] Michalski MH, Ross JS. The shape of thing to come: 3D printing in medicine[J]. JAMA, 2014, 312(21): 2213-2214.
[17] 王俊杰. 3D打印技术与精准粒子植入治疗学[M].北京: 北京大学医学出版社, 2016:65-78.
[18] 张颖, 林琦, 韩明勇,等. 3D 打印个体化模板联合CT引导治疗胸壁肿瘤1例[J]. 山东大学学报(医学版), 2016, 54(4): 94-96.
[19] 张颖, 林琦, 韩明勇, 等. 3D打印个体化模板联合CT引导125I粒子植入治疗恶性肿瘤质量评价[J]. 山东大学学报(医学版), 2016, 54(11): 44-50. ZHANG Ying, LIN Qi, HAN Mingyong, et al. The feasibility of 3D print individual template combination with CT guided iodine-125 seed implantation for malignancy[J]. Journal of Shandong University(Health Science), 2016, 54(11): 44-50.
[20] Keyes M, Morris WJ, Spadinger I, et al. Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program[J]. Brachytherapy, 2013, 12(4): 343-355.
[21] 张宏涛, 底学敏, 王娟,等. 3D打印模板引导125I粒子植入术前术后剂量对比[J]. 中华医学杂志, 2016, 96(9): 712-715. ZHANG Hongtao, DI Xuemin, WANG Juan, et al. Dose comparison between pre and post operation of 125I seed implantation guided by 3D print template[J]. National Medical Journal of China, 2016, 96(9): 712-715.
[1] 林琦,张颖,袁苑,戴建建,徐瑞彩,杨琦,耿宝成,韩明勇. 肾上腺转移瘤放射性125I粒子植入治疗后胃穿孔1例[J]. 山东大学学报（医学版）, 2017, 55(7): 124-129.
[2] 曹倩倩,姜玉华,李玉亮,杨瑞杰,刘路,张喜乐,王俊杰. 放射性125I粒子植入与外放疗治疗颈椎转移瘤剂量学对比分析[J]. 山东大学学报（医学版）, 2017, 55(7): 55-60.
[3] 柴树德. 我国放射性粒子植入治疗支气管肺癌现状与技术创新[J]. 山东大学学报（医学版）, 2017, 55(2): 4-7.
[4] 戴建建,袁冰,张颖,林琦,袁苑,韩明勇. CT引导下125I粒子植入治疗Ⅲ期非小细胞肺癌疗效与并发症的临床观察[J]. 山东大学学报（医学版）, 2017, 55(2): 32-37.
[5] 林琦,张颖,戴建建,徐瑞彩,杨琦,耿宝成,韩明勇. CT引导放射性125I粒子植入治疗23例浅表淋巴结转移瘤[J]. 山东大学学报（医学版）, 2017, 55(2): 38-44.
[6] 许玉军,柳明,何祥萌,李成利. 1.0T开放型磁共振引导经皮穿刺125I放射性粒子植入治疗晚期胰腺癌[J]. 山东大学学报（医学版）, 2017, 55(2): 21-25.
[7] 李扬,何闯,陈玉潇,杨丽,李良山,李廷源,黄学全. 放射性125I粒子植入近距离治疗长骨转移瘤的临床疗效[J]. 山东大学学报（医学版）, 2017, 55(2): 50-54.
[8] 袁苑,张颖,林琦,戴建建,李冉冉,徐瑞彩,杨琦,耿宝成,韩猛,韩明勇. 125I粒子植入术后应用透明质酸钠凝胶皮下注射保护皮肤1例[J]. 山东大学学报（医学版）, 2017, 55(11): 89-92.
[9] 王丽丽,霍彬,王磊,汪浩,侯定坤,霍小东,王金焕,臧立,曹强,柴树德,王海涛. 亚肺叶切除联合125I粒子植入治疗早期肺癌有效性的Meta分析与系统评价[J]. 山东大学学报（医学版）, 2017, 55(10): 76-83.
[10] 张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导125I粒子植入治疗胸壁转移瘤1例[J]. 山东大学学报（医学版）, 2016, 54(4): 94-96.
[11] 孔祥骞,王默,董典宁,种振岳,金星. 3D打印辅助开窗技术腔内修复治疗近肾动脉腹主动脉瘤[J]. 山东大学学报（医学版）, 2016, 54(3): 91-94.
[12] 房菲菲,张颖,林琦,袁苑,戴建建,徐瑞彩,耿宝成,韩明勇. CT引导放射性125I粒子植入治疗转移性肝癌的临床疗效[J]. 山东大学学报（医学版）, 2016, 54(12): 53-57.
[13] 张颖,林琦,袁苑,戴建建,耿宝成,徐瑞彩,刘亚坤,韩明勇. 3D打印个体化模板联合CT引导125I粒子植入治疗恶性肿瘤质量评价[J]. 山东大学学报（医学版）, 2016, 54(11): 44-50.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发